Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Acutus Medical, Inc. (AFIB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
0.8800-0.0292 (-3.21%)
At close: 04:00PM EDT
0.9910 +0.11 (+12.61%)
After hours: 07:09PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Slow Stochastic

Slow Stochastic

Previous Close0.9092
Open0.8800
Bid0.8810 x 1800
Ask0.8966 x 900
Day's Range0.8800 - 0.9641
52 Week Range0.4800 - 9.1500
Volume52,646
Avg. Volume482,931
Market Cap24.966M
Beta (5Y Monthly)1.09
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for AFIB

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Acutus Medical, Inc.
    ITOS: What does Argus have to say about ITOS?ITEOS THERAPEUTICS INC has an Investment Rating of HOLD; a target price of $21.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
    Rating
    Fair Value
    Economic Moat
    3 days agoArgus Research
View more
  • Motley Fool

    Acutus Medical, Inc. (AFIB) Q2 2022 Earnings Call Transcript

    Joining me on today's call is David Roman, chief executive officer and chief financial officer. This call will include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements made on this call do not relate to matters of historical fact should be considered forward-looking statements.

  • Benzinga

    Why Acutus Medical Shares Are Rallying Today?

    Acutus Medical Inc (NASDAQ: AFIB) has launched an expanded suite of left-heart access products, including the AcQCross Qx system for use with the TruSeal and FXD delivery system for the Watchman LAAC Device. AcQCross is a transseptal system engineered with an integrated needle and dilator to reduce the multiple exchanges of wires and needles while trying to achieve the proper angle and location on the septum. Related: Acutus Medical Stock Soars On Debt Refinancing, Divestiture Of Left-Heart Acce

  • Motley Fool

    Acutus Medical, Inc. (AFIB) Q1 2022 Earnings Call Transcript

    Thank you for standing by, and welcome to the Acutus Medical, Inc. first quarter 2022 earnings conference call. Joining me on today's call are Scott Huennekens, chairman of Acutus's board of directors; and David Roman, interim chief executive officer and chief financial officer. This call will include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.

Advertisement
Advertisement